COAPT
2018
Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy
In 614 patients with HF and severe secondary mitral regurgitation, MitraClip plus GDMT reduced HF hospitalisation and all-cause mortality compared with GDMT alone.
Result
Efficacy: HF hospitalisation rateHR 0.53
Below 1 favours MitraClip plus GDMT, above 1 favours GDMT alone.
Event rates MitraClip plus GDMT 35.8 vs GDMT alone 67.9 per 100 patient-years
Also reported: Mortality 29.1 % vs 46.1 %.
- Subtopic
- Mitral
- Design
- RCT, 2 yr
- Relevance
- Practice-defining: a trial the guidelines cite as evidence.
- Cited in
- ESC 2025 VHDACC/AHA 2020 VHD
- Source
- Stone GW, et al. N Engl J Med. 2018;379(24):2307-2318.doi 10.1056/NEJMoa1806640
Discussion & critique
MITRA-FR (same year, French) was negative; patient selection (disproportionate MR vs LV dilation) explains the divergence. Identifying COAPT-like anatomy is the practical takeaway.